Movement Alert|Lingyi iTech Rises 3.04% in Regular Trading, Apple Foldable iPhone Mass Production Progress Boosts Supply Chain Sentiment

Market Focus07-09

On July 9, Lingyi iTech rose 3.04% in regular trading, trading at HK$7.80/share, with turnover of HK$129 million.

On the news front, Apple's first foldable iPhone mass production continues to advance without delays. Supply chain sources indicate the production target has been raised from 7-8 million units to approximately 10 million units, with large-scale mass production expected to commence before year-end. Lingyi iTech serves as Apple's exclusive supplier of carbon fiber inner support plates, ultra-thin VC vapor chamber heat dissipation modules, and anti-collapse brackets for the foldable device. The per-unit component value is significantly higher than that of standard slab-style models, positioning the company as a direct beneficiary of increased new device inventory buildup.

The company's H shares listed on June 26 at an issue price of HK$10.18 and have since traded below their IPO price. The foldable screen production catalyst has helped drive a short-term recovery in market sentiment, partially offsetting persistent post-IPO selling pressure.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment